Log in or Sign up for Free to view tailored content for your specialty!
HF/Transplantation News
Sodium restriction may not impact morbidity, mortality in patients with heart failure
A narrative review found no evidence that sodium restriction affects morbidity and mortality in patients with heart failure.
Wegovy improves functional class in patients with obesity, heart failure at 1 year
In patients with obesity-driven heart failure with preserved ejection fraction, semaglutide 2.4 mg was associated with more improvement in NYHA functional class compared with placebo, according to new data from the STEP-HFpEF trials.
Log in or Sign up for Free to view tailored content for your specialty!
Pulmonary artery sensor for remote heart failure management nets premarket approval
Endotronix announced the FDA has given premarket approval to its pulmonary artery sensor system for the treatment of NYHA class III heart failure.
Vutrisiran reduces mortality, CV events in ATTR amyloidosis with cardiomyopathy
Alnylam Pharmaceuticals announced the positive top-line results of the phase 3 HELIOS-B trial of its investigational RNA interfering therapy vutrisiran for the treatment of transthyretin amyloidosis with cardiomyopathy.
Depression during pregnancy linked to elevated risk for heart disease
Depressive symptoms during pregnancy may indicate elevated cardiovascular risk for women, especially hypertension, ischemic heart disease and heart failure, according to a study published in the European Heart Journal.
Liraglutide better at preventing heart outcomes vs. three other glucose-lowering therapies
PHILADELPHIA — In the cardiovascular outcomes analysis of the GRADE trial, liraglutide was linked to lower risk for certain CV outcomes compared with other glucose-lowering therapies, researchers reported.
Black Americans had nearly 800,000 excess cardiovascular deaths from 2000 to 2022
Reflecting disparities in cardiovascular care, there were nearly 800,000 excess CV deaths among Black Americans between 2000 and 2022, according to a “report card” published in the Journal of the American College of Cardiology.
Algorithm can help optimize device therapy for patients with HFrEF
HF is associated with a fourfold increased risk for death and a sixfold to ninefold increased risk for sudden cardiac death, and its direct and indirect costs are estimated to reach $69.8 billion annually in the United States by 2030.
Weekly yoga practice improves symptoms, activity levels among patients with heart failure
Adults with HF who practiced weekly yoga for 1 year had greater improvements in heart health than those receiving medical management alone, according to a poster presented at the European Society of Cardiology’s Heart Failure 2024 meeting.
Two intra-aortic balloon catheter kits recalled; three deaths reported
Teleflex and its subsidiary Arrow International issued a recall of its intra-aortic balloon catheter kits due to a manufacturing error that may cause the balloon to become overtwisted.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read